Evidence map›Paper›PMID 39493747›Full record

ArticleFrontiers in allergy2024

Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms.

Matthew J Hamilton, Loren W Greene, Lauren M Madigan, Sa A Wang, Cecilia Arana Yi, Andrew Kuykendall, Tracy I George, Mariana C Castells

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Management of skeletal-related events and fracture prevention in systemic mastocytosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Matthew J HamiltonDivision of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Loren W GreeneDepartment of Medicine, NYU Grossman School of Medicine, New York, NY, United States.
Lauren M MadiganDepartment of Dermatology, University of Utah, Salt Lake City, UT, United States.
Sa A WangDivision of Pathology-Lab Medicine Division, Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, United States.
Cecilia Arana YiDivision of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, United States.
Andrew KuykendallDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, United States.
Tracy I GeorgeARUP Laboratories, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
Mariana C CastellsDepartment of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic mastocytosis (SM) is a rare hematologic condition characterized by the proliferation and accumulation in tissue of clonal mast cells in multiple organ systems. The release of mast cell mediators in the indolent disease type and the predominant mast cell infiltration of tissues in advanced disease contribute to the heterogeneous clinical presentation. The disease driver in >90% of adult cases is an activating

Indexed as

anaphylaxiscase reportindolent systemic mastocytosisKIT mutationtryptasetyrosine kinase

Identifiers

PMID39493747
PMCPMC11527781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.